- Report
- August 2022
- 40 Pages
Vietnam
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
South Korea
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
Saudi Arabia
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
Russia
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
Japan
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
Ireland
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
India
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
Germany
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
France
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
China
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 40 Pages
Brazil
From €1373EUR$1,500USD£1,167GBP
- Report
- August 2022
- 100 Pages
Global
From €2289EUR$2,500USD£1,945GBP
From €1373EUR$1,500USD£1,167GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €1373EUR$1,500USD£1,167GBP
- Report
- May 2022
- 40 Pages
United States
From €1373EUR$1,500USD£1,167GBP
- Report
- February 2022
- 62 Pages
Global
From €3204EUR$3,500USD£2,723GBP
- Drug Pipelines
- November 2020
- 52 Pages
Global
From €3204EUR$3,500USD£2,723GBP
- Report
- March 2025
- 50 Pages
Kenya
From €549EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Nigeria
From €549EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Egypt
From €549EUR$600USD£467GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more